News from NORD

More Than 100 Patient Organizations Join NORD in Supporting the RARE Act


 

NORD has sent a letter to Congress, signed by more than 100 patient advocacy organizations, in support of the Rare disease Advancement, Research, and Education Act of 2018 (H.R.5115) or the “RARE Act of 2018.” Read NORD’s letter to see how this proposed legislation would help patients and families affected by rare diseases, medical researchers, and clinicians seeking to provide optimal care for their patients.

Recommended Reading

Ehlers-Danlos Society
Clinician Reviews
International Pemphigus and Pemphigoid Foundation
Clinician Reviews
MDS Foundation
Clinician Reviews
Morgan Leary Vaughan Foundation
Clinician Reviews
Osteogenesis Imperfecta Foundation (OIF)
Clinician Reviews
Neuropathic Pain in MS
Clinician Reviews
Study supports meningococcal B vaccine in children with rare diseases
Clinician Reviews
Register Now for NORD’s Rare Impact Awards Celebration
Clinician Reviews
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
Clinician Reviews
RFPs Available for the Study of Three Rare Diseases
Clinician Reviews